Table 4.
Multiple regression model results: anxiety disorder diagnosis (N=2892)
| Outcome variables | Pain severity |
Opioid Analgesics |
Non-opioid analgesics |
||||||
|---|---|---|---|---|---|---|---|---|---|
| β | 95% CI |
β | 95% CI |
β | 95% CI |
||||
| LL | UL | LL | UL | LL | UL | ||||
| Predictor variables | |||||||||
| Maximum Pain Score | – | – | – | 0.60*** | 0.56 | 0.64 | 0.26*** | 0.22 | 0.30 |
| Anxiety disorder diagnosis | 0.13*** | 0.10 | 0.15 | − 0.09*** | − 0.11 | − 0.05 | 0.01 | 0.00 | 0.03 |
| Maximum pain score × anxiety disorder diagnosis | – | – | – | − 0.07*** | − 0.09 | − 0.05 | 0.04** | 0.03 | 0.05 |
| Covariates | |||||||||
| Year | 0.03* | 0.00 | 0.06 | − 0.05*** | − 0.06 | − 0.04 | 0.03* | 0.02 | 0.04 |
| Age | 0.10*** | 0.07 | 0.13 | 0.01 | 0.00 | 0.02 | − 0.01 | − 0.02 | 0.00 |
| Sex | − 0 07*** | − 0.10 | − 0.05 | 0.10*** | 0.09 | 0.11 | − 0.02 | − 0.03 | − 0.01 |
| Hispanic ethnicity | 0.04** | 0.01 | 0.07 | 0.00 | − 0.02 | 0.01 | − 0.01 | − 0.02 | 0.00 |
| Medicare/Medi-Cal | − 0.03 | − 0.06 | 0.00 | 0.01 | 0.00 | 0.02 | 0.02 | 0.01 | 0.03 |
| Length of stay | 0.11*** | 0.08 | 0.14 | 0.08*** | 0.07 | 0.09 | 0.07*** | 0.06 | 0.08 |
| Mood disorder diagnosis | 0.03 | 0.00 | 0.06 | − 0.11*** | − 0.13 | − 0.09 | − 0.01 | − 0.02 | 0.00 |
| Bacterial and viral infections | − 0.02 | − 0.05 | 0.02 | − 0.01 | − 0.02 | 0.00 | 0.00 | − 0.01 | 0.01 |
| Blood diseases | − 0.05** | − 0.08 | − 0.01 | 0.03* | 0.02 | 0.04 | − 0.05*** | − 0.06 | − 0.04 |
| Endocrine, nutritional, and metabolic diseases | − 0.01 | − 0.05 | 0.02 | − 0.06*** | − 0.08 | − 0.04 | − 0.04** | − 0.05 | − 0.03 |
| Diseases of the nervous system | − 0.07*** | − 0.10 | − 0.04 | − 0.08*** | − 0.09 | − 0.07 | 0.03* | 0.02 | 0.04 |
| Diseases of the circulatory system | 0.00 | − 0.03 | 0.03 | 0.04** | 0.03 | 0.05 | − 0.04** | − 0.05 | − 0.03 |
| Diseases of the respiratory system | − 0.05** | − 0.08 | − 0.01 | 0.01 | − 0.01 | 0.03 | 0.01 | 0.00 | 0.02 |
| Diseases of the digestive system | 0.05** | 0.02 | 0.08 | 0.04** | 0.03 | 0.05 | 0.03* | 0.02 | 0.04 |
| Diseases of the musculoskeletal system and connective tissue | 0.02 | − 0.01 | 0.05 | 0.10*** | 0.09 | 0.11 | 0.08*** | 0.07 | 0.09 |
| Diseases of the genitourinary system | − 0.04** | − 0.08 | − 0.01 | 0.06*** | 0.05 | 0.07 | 0.00 | − 0.01 | 0.01 |
| Congenital malformations, deformations and chromosomal abnormalities | − 0.02 | − 0.05 | 0.02 | 0.10*** | 0.09 | 0.11 | 0.01 | 0.00 | 0.02 |
| Injury, poisoning and certain other consequences | − 0.02 | − 0.05 | 0.01 | 0.16*** | 0.15 | 0.17 | − 0.02 | − 0.03 | − 0.01 |
| Other mental, behavioral and neurodevelopmental disorders | − 0.09*** | − 0.12 | − 0.05 | − 0.14*** | − 0.16 | − 0.12 | − 0.04** | − 0.05 | − 0.03 |
| Opioid analgesics | 0.34*** | 0.30 | 0.37 | 0.10*** | 0.09 | 0.11 | |||
| Non-opioid analgesics | 0.28*** | 0.24 | 0.31 | 0.18*** | 0.17 | 0.19 | – | – | – |
Estimates represent standardized coefficients CI confidence interval, LL lower limit, UL upper limit
*
p < .05,
**
p < .01,
***
p< .001